Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3466249 A
Publication typeGrant
Publication dateSep 9, 1969
Filing dateFeb 13, 1967
Priority dateFeb 13, 1967
Also published asDE1698180A1, DE1698180B2, DE1698180C3
Publication numberUS 3466249 A, US 3466249A, US-A-3466249, US3466249 A, US3466249A
InventorsAnderson Roy A
Original AssigneeBaxter Laboratories Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Blood serum reference standard for multi-automated analytical procedures
US 3466249 A
Images(2)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent 3,466,249 BLOOD SERUM REFERENCE STANDARD FOR MULTI-AUTOMATED ANALYTICAL PROCEDURES Roy A. Anderson, North Hollywood, Calif., assignor to Baxter Laboratories, Inc., Morton Grove, 11]., a corporation of Delaware No Drawing. Filed Feb. 13, 1967, Ser. No. 615,339 Int. Cl. C09k 3/00 U.S. Cl. 252-408 4 Claims ABSTRACT OF THE DISCLOSURE A stable blood serum reference standard having a standard carbon dioxide content for use in multi-automated analytical procedures in which a freeze-dried blood serum component of the reference standard is reconstituted with an aqueous ammonium bicarbonate component of the reference standard.

This invention relates to a laboratory standard material and, more particularly, to a stable blood serum reference standard and to a method of preparation and use thereof.

The rapid quantitation or estimation of various blood serum components has become a valuble adjunct in the clinical diagnosis of disease. In recent years a number of elaborate electronic devices have been developed for making rapid and precise analytical determinations on blood serum and other biochemical samples. An automatic analyzer known as the Robot Chemist made by Warner-Chilcott Laboratories and various instruments known by the name AutoAnalyzer made by Technicon Instruments are examples of such electronic devices capable of making rapid and precise analytical determinations. Some of the various biochemical determinations which the above and similar electronic devices are presently adaptable to are, for example, albumin, acid phosphatase, alkaline, phosphatase, bilirubin, calcium, carbon dioxide, chloride, cholesterol, glucose, hemoglobin, LDH, potassium, sodium, total protein, transaminase, urea nitrogen and uric acid. One particular instrument available on the market (known as the 12 Channel AutoAnalyzer) is capable of simultaneously making twelve different analyses on a single sample.

In the performance of the analytical tests made by the above and similar electronic devices on blood serum and other biological samples, it is necessary to use laboratory standard materials or so-called reference standards for purposes of calibration and control of the instrument. Accurate results in the use of these instruments, particularly in the case of multi-automated procedures, are dependent upon rigid and constant standardization of the biochemical determinations.

Since blood is a complex material which contains numerous substances, multi-automated procedures lend themselves ideally to the analysis of blood. Of the many functions of blood, an important one is to carry raw materials to the tissues and remove the waste products therefrom. One of the most essential of these raw materials is oxygen, and an important waste product is carbon dioxide which the hemoglobin of the red cells carries away from the tissues to which it has delivered oxygen. Also, the carbon dioxide in normal blood is maintained in equilibrium with H CO and HCO to comprise an important buffering system for controlling the pH of the blood. Consequently, determination of the carbon dioxide content of the blood serum is of great importance in many clinical procedures. A multi-automated procedure which includes an arcuate determination of the carbon ice dioxide content of blood would, therefore, be very useful in the clinical laboratory.

Accordingly, it is an object of this invention to provide a stable blood serum reference standard which includes a standard carbon dioxide content.

It is another object of this invention to provide a stable blood serum reference standard which includes a standand carbon dioxide content and which can be used for calibration and control of multi-automated analytical procedures.

As used herein, the term carbon dioxide content refers to the total equivalent amount of carbon dioxide in the form of CO H CO and HCO As used herein, the term multi-automated procedure refers to an automated chemical analytical procedure in which two or more analyses are made simultaneously on a single sample.

In brief, the blood serum reference standard of the present invention comprises a freeze-dried serum prepared from human blood and a separate aqueous solution of ammonium bicarbonate for use in reconstitution of the freeze-dried serum.

The freeze-dried serum used in the practice of this invention is stable for at least two years at temperatures ranging from about 2 to about 10 C. In the method of this invention, the freeze-dried serum is reconstituted with sufficient aqueous ammonium bicarbonate solution (a) to provide from about 12 to about 35 meq./liter of carbon dioxide content in the reconstituted serum or (b) to increase the carbon dioxide content of the reconstituted serum to any predetermined level, depending upon the particular analytical procedure concerned. This reconstituted serum is stable for at least three days at temperatures ranging from about 2 to about 10 C., and is directly used for the calibration and control of the instruments used in the multi-automated analytical procedures.

The freeze-dried serum used in the practice of the present invention can be prepared by any conventional method of freeze-drying whereby the serum is dried from the frozen state under a high vacuum and ice or other frozen solvent rapidly sublimes to yield a porous solid.

The use of the separate aqueous solution of the ammonium bicarbonate for reconstitution of the freeze-dried serum has been found necessary according to the present invention to provide a stable blood serum reference standard. It has been found that in the freeze-drying of the blood serum, a substantial amount of the carbon dioxide content of the serum is lost in the form of gaseous CO And in order to preserve enzymes in the serum, acid is added to provide the optimum pH at which the enzymes remain active. This acidification causes even further losses in the carbon dioxide content of the serum.

The ammonium bicarbonate reconstituting solution is uniquely suited as a component of the blood serum reference standard of this invention in that:

(1) It is stable in solution when hermetically sealed and sterilized.

(2) It has a composition that does not cause interference with measurement of any of the constituents of blood ordinarily tested in multi-automated analytical procedures.

(3) It has a composition that does not undesirably contribute constituents which would throw otf any of the ordinary target values for the blood serum reference standard, i.e., values substantially the same as in normal human blood serum or values ideally suited to multi-automated analytical procedures.

(4) It has a pH in such a range that the final pH (e.g., pH 7510.5) of the reconstituted serum is within an acceptable range for the test systems as well as for stability of the components, particularly the enzymes.

(5) It contributes to the carbonate-bicarbonate system when added to the serum to produce a carbon dioxide content that is suitable for standardizing and controlling the test.

(6) It has no color and can be filtered to produce a water-clear solution.

The following example will further illustrate the present invention although the invention is not limited to this specific example which is provided by Way of illustration and not limitation.

EXAMPLE A solution of ammonium bicarbonate was prepared by dissolving 426.6 g. of ammonium bicarbonate (A.R. grade) in 180 liters of distilled water. The solution was clarified by passage through Millipore membranes (1.2 and 0.45 micron), filled into 50 ml. bottles, stoppered, hermetically sealed and then sterilized by autoclaving at 255 F. for 30 minutes.

Freeze-dried human blood serum representing an original volume of 50 m1. of liquid serum was reconstituted to its original volume by the addition of 50 ml. of the above ammonium bicarbonate solution. The mixture was slightly agitated by rotation of the bottle to completely wet the serum with the aqueous solution and then placed in a refrigerator until the serum was completely dissolved. A sample of the reconstituted serum had the following analysis:

Constituent: Mean value Albumin, g./100 ml. 3.9 Alkaline phosphatase, units 18 1 Bilirubin, mg./l00 ml. 1.8 Calcium, mg./ 100 ml. 9.0 Chloride, meq./l. 101 Carbon dioxide content, meq./l. 25 1 Glucose, mg./100 ml. 230 Potassium, rneq./l. 5.0 Sodium, meq./l. 140 Total protein, g./100 ml. 6.8 1 Transaminase (GOT), units 100 Urea nitrogen, mg./l00 ml. 68

These values are in an elevated range. The liquid serum was preadjusted (prior to freeze-drying) by the addition of pure compounds and other substances to give values in certain ideal ranges for standardizing nlulti-channel automated instruments such as the "12 Channel AutoAnalyzer.

The above reconstituted serum can be used for the standardization and control of multi-automated analytical procedures for blood serum such as with the 12 Channel AutoAnalyzer made by Technicon Instruments.

As will be readily apparent to those skilled in the art,

other examples of the herein-defined invention can be devised after reading the foregoing specification and the claims appended hereto by various modifications, variations and adaptations without departing from the spirit and scope of the invention. All such modifications, variations and adaptations are included within the scope of the invention as defined in the appended claims.

What is claimed is:

1. A blood serum reference standard comprising a first container of freeze-dried blood serum and a second container of aqueous ammonium bicarbonate, the concentration of said aqueous ammonium bicarbonate being such that when the serum is reconstituted with the aqueous ammoniurn bicarbonate the carbon dioxide content of the reconstituted serum is from about 12 to about meq./ liter.

2. The method of providing an accurate blood serum reference standard including a standard carbon dioxide content for use in multi-automated analytical procedures comprising reconstituting freeze-dried blood serum with an aqueous solution of ammonium bicarbonate such that the carbon dioxide content of the reconstituted serum is increased to a predetermined level.

3. The method of providing an accurate blood serum 0 reference standard including a standard carbon dioxide UNITED STATES PATENTS 2,225,744 12/1940 Flosdorf 252-408 2,770,602 11/1956 Weichselbaum 252-408 3,000,836 9/1961 Ginsburg 252408 3,147,081 9/1964 Stevenson et a1.

MORRIS O. WOLK, Primary Examiner R. E. SERWIN, Assistant Examiner US. Cl. X.R.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2225744 *Aug 25, 1938Dec 24, 1940Commw Edison CoProcess of removing and recovering sulphur dioxide
US2770602 *Oct 15, 1953Nov 13, 1956Aloe Company AsMethod of preparing protein standardized reagents
US3000836 *Sep 2, 1958Sep 19, 1961Ben GinsburgStabilized whole blood standard and method of making the same
US3147081 *Feb 27, 1961Sep 1, 1964Beckman Instruments IncTechnique in blood testing
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3859049 *Feb 1, 1974Jan 7, 1975Marbach Edward PBlood reference standard and process for blood gas test
US3897363 *Aug 10, 1973Jul 29, 1975Baxter Laboratories IncBlood control standard
US3973913 *Jan 29, 1976Aug 10, 1976Louderback Allan LeeBlood control standard
US4001142 *Jul 25, 1975Jan 4, 1977Warner-Lambert CompanyBlood gas control
US4056484 *Dec 29, 1975Nov 1, 1977Behringwerke AktiengesellschaftStable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests
US4121905 *Aug 22, 1977Oct 24, 1978Jonas MaurukasProcess for preparing biological compositions for use as reference controls in diagnostic analyses
US4141856 *May 9, 1977Feb 27, 1979Dorwart Jr William VQuaternary ammonium carbonate
US4158544 *Jul 17, 1978Jun 19, 1979Beckman Instruments, Inc.Serum proteins
US4163734 *Jan 5, 1978Aug 7, 1979Radiometer A/SReference liquid for blood gas equipment
US4219440 *Jun 6, 1979Aug 26, 1980Coulter Electronics, Inc.Multiple analysis hematology reference control reagent and method of making the same
US4287087 *Aug 2, 1978Sep 1, 1981Research Triangle InstituteFixed-dried blood platelets
US4323478 *Dec 19, 1979Apr 6, 1982Baxter Travenol Laboratories, Inc.Lyophilized blood plasma proteins
US4324685 *Mar 21, 1980Apr 13, 1982Beckman Instruments, Inc.Water soluble amine chloride
US4325832 *Jan 21, 1980Apr 20, 1982Beckman Instruments, Inc.Enzyme reference composition
US4351743 *Mar 31, 1977Sep 28, 1982Yoshikazu HashimotoDilute standard gases prepared by utilizing buffered solution, method for preparation thereof and apparatus therefor
US4458021 *May 3, 1982Jul 3, 1984American Hospital Supply CorporationBlood gas control
US4485174 *Sep 29, 1982Nov 27, 1984Instrumentation Laboratory Inc.Hemoglobin-based blood gas control
US4960708 *Oct 13, 1988Oct 2, 1990Baxter International Inc.Pressurized packaged reference liquid for blood gas analysis
US5204266 *Jul 24, 1989Apr 20, 1993Instrumentation Laboratory SpaMethod and apparatus for liquid phase calibration of oxygen and carbon dioxide partial pressure
US5296377 *Dec 15, 1992Mar 22, 1994Boehringer Mannheim CorporationControl reagent containing a hydroxylamine or an antioxidant
US5308767 *Jul 20, 1992May 3, 1994Fuji Photo Film Co., Ltd.Method for control or calibration in a chemical analytical determination
US5547874 *Apr 5, 1995Aug 20, 1996Fuji Photo Film Co., Ltd.Method for control or calibration in a chemical analytical determination
US6268481Jul 22, 1997Jul 31, 2001Medical Analysis Systems, Inc.Covalently coupled troponin complexes
US20110201121 *Aug 24, 2006Aug 18, 2011Berggren Oy AbMethod of testing a liquid sample, a test unit, and an automatized system of a plurality of test units
CN101930009BNov 19, 2009Sep 11, 2013首都医科大学附属北京朝阳医院Serum calcium standard substance
DE2723070A1 *May 21, 1977Dec 15, 1977Dorwart JunBezugspraeparat zur festlegung einer anionenkonzentration bei chemischen analysen
DE2856988C1 *Aug 22, 1978Jan 26, 1984Jonas MaurukasVerfahren zur Herstellung von biologischen Zusammensetzungen fuer die Verwendung als Bezugs-Kontrollproben bei der diagnostischen Analyse
EP0358250A2 *Jul 25, 1989Mar 14, 1990INSTRUMENTATION LABORATORY S.p.A.Method and apparatus for liquid phase calibration of oxigen and carbon dioxide partial pressure
WO1979000106A1 *Aug 22, 1978Mar 8, 1979Maurukas JProcess for preparing biological compositions for use as a reference control in diagnostic analysis
WO1983003902A1 *Apr 4, 1983Nov 10, 1983American Hospital Supply CorpBlood gas control
Classifications
U.S. Classification436/11, 436/16, 436/18
International ClassificationG01N33/96
Cooperative ClassificationG01N33/96, G01N2496/05, G01N2496/80, G01N2496/70
European ClassificationG01N33/96
Legal Events
DateCodeEventDescription
Nov 2, 1982ASAssignment
Owner name: COOPER LABORATORES, INC., 3145 PORTER DRIVE, PALO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:BAXTER TRAVENOL LABORATORIES, INC., A CORP. OF DE;REEL/FRAME:004067/0785
Effective date: 19820917